Prosztatarák: vizsgálatok itt: Portugália
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Lisbon, Loures, Porto
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 3. fázisTaking peopleA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Braga, Cascais, Lisbon, Porto, Vila Nova de Gaia
- Életkor
- 18 év and over
- People
- 1314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00 - 3. fázisTaking peopleA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Lisbon, Porto, Vila Nova de Gaia
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674 - No phaseTaking peopleA Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Where
- Many Locations
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Bayer
See details and how to joinNCT07344779 - 3. fázisTaking peoplePhase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Lisbon, Porto, Vila Nova de Gaia
- Életkor
- 18 év and over
- People
- 297 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-520555-89-00 · EU 2025-520555-89-00 - 1. fázisTaking peopleStudy of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Lisbon, Porto
- Életkor
- 18 év and over
- People
- 479 worldwide
- Run by
- Amgen
See details and how to joinNCT04221542 · EU 2023-504361-23-00 - No phaseTaking peopleE-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Sexual Health of Prostate Cancer Survivors
- Where
- Porto
- Életkor
- 18 év and over
- People
- 106
- Run by
- Universidade do Porto
See details and how to joinNCT07754929 - 3. fázisTaking peoplePhase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
- Where
- Braga, Guimaraes
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
See details and how to joinNCT07333066 · EU 2025-524408-30-01 - No phaseTaking peopleSingle-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)
- Where
- Lisbon
- Életkor
- 18 év and over
- People
- 200
- Run by
- Fundacao Champalimaud
See details and how to joinNCT04035642